PRO40 BUDGET IMPACT ANALYSIS OF IDURSULFASE BETA IN THE TREATMENT MUCOPOLYSACCHARIDOSIS TYPE II IN THE RUSSIAN FEDERATION
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2370
https://www.valueinhealthjournal.com/article/S1098-3015(19)34748-5/fulltext
Title :
PRO40 BUDGET IMPACT ANALYSIS OF IDURSULFASE BETA IN THE TREATMENT MUCOPOLYSACCHARIDOSIS TYPE II IN THE RUSSIAN FEDERATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34748-5&doi=10.1016/j.jval.2019.09.2370
First page :
Section Title :
Open access? :
No
Section Order :
12071